| 000 | 01866 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518052244.0 | ||
| 264 | 0 | _c20190910 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1090-2449 | ||
| 024 | 7 |
_a10.1016/j.exppara.2019.107728 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKhayeka-Wandabwa, Christopher | |
| 245 | 0 | 0 |
_aCombined chemotherapy manifest less severe immunopathology effects in helminth-protozoa comorbidity. _h[electronic resource] |
| 260 |
_bExperimental parasitology _cSep 2019 |
||
| 300 |
_a107728 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnthelmintics _xadministration & dosage |
| 650 | 0 | 4 |
_aAntimony Sodium Gluconate _xadministration & dosage |
| 650 | 0 | 4 |
_aAntiprotozoal Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aChemokine CCL3 _xblood |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aInterferon-gamma _xblood |
| 650 | 0 | 4 |
_aLeishmania major _xdrug effects |
| 650 | 0 | 4 |
_aLeishmaniasis, Cutaneous _xcomplications |
| 650 | 0 | 4 |
_aLiver _xparasitology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aPraziquantel _xadministration & dosage |
| 650 | 0 | 4 |
_aSchistosoma mansoni _xdrug effects |
| 650 | 0 | 4 |
_aSchistosomiasis mansoni _xcomplications |
| 700 | 1 | _aZhou, Guan | |
| 700 | 1 | _aMagak, Ng'wena Gideon | |
| 700 | 1 | _aChoge, Joseph K | |
| 700 | 1 | _aKemei, William Kipchirchir | |
| 700 | 1 | _aMakwali, Judith Alice | |
| 700 | 1 | _aKarani, Lucy Wanja | |
| 700 | 1 | _aKisavi, Mutila Phoebe | |
| 700 | 1 | _aNdulu, James V | |
| 700 | 1 | _aAnjili, Christopher O | |
| 773 | 0 |
_tExperimental parasitology _gvol. 204 _gp. 107728 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.exppara.2019.107728 _zAvailable from publisher's website |
| 999 |
_c29943228 _d29943228 |
||